Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risk management from a collaborative perspective.

Kenneth R Baker1

  • 1Pharmacists Mutual Insurance Company, Algona, Iowa, USA.

Journal of the American Pharmacists Association : Japha
|November 25, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insurance for the Compounding Business, Part 1: Who is Covered?

International journal of pharmaceutical compounding·2013
Same author

Insurance for the compounding pharmacy business, part 2: what, when, and where.

International journal of pharmaceutical compounding·2013
Same author

The impact of HIPAA on pharmacy.

The Annals of pharmacotherapy·2003
Same journal

Healthcare cost savings through hospital pharmacist-collaborative care in heart failure: A microsimulation study.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Assessment of comprehensive medication management incorporating a patient-completed medical and medication history form in community practice.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Characterizing how community pharmacy teams engage with social drivers of health (SDOH) during routine workflow: A report from the medication safety research network of Indiana (Rx-SafeNet).

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Geographic disparities in board-certified ambulatory care pharmacists in Appalachia.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Development of consensus criteria for problematic medications in active duty service members.

Journal of the American Pharmacists Association : JAPhA·2026
Same journal

Barriers and facilitators to pharmacy-based methadone dosing and dispensing: Semi-structured interviews with pharmacists.

Journal of the American Pharmacists Association : JAPhA·2026
See all related articles

Medication errors causing harm, especially with high-risk drugs like warfarin, can be reduced. Pharmacist-physician collaboration and continuous quality improvement are key to preventing these errors.

Area of Science:

  • Pharmacovigilance and medication safety.
  • Clinical pharmacy and healthcare systems analysis.

Background:

  • Medication error studies differ from claims analyses; the latter identifies errors causing harm.
  • High-risk and narrow therapeutic index agents, such as warfarin, are disproportionately represented in claims data due to the severity of associated errors.

Framework:

  • Collaborative relationships between pharmacists and physicians are crucial for medication error reduction.
  • A framework for error prevention involves risk identification, technique selection, system monitoring, and continuous quality improvement.

Implementation:

  • Pharmacists can actively identify potential risks and implement strategies to mitigate them.
  • Continuous monitoring and reevaluation of medication systems are essential for ongoing safety improvements.

Related Experiment Videos

Implications:

  • Implementing a systematic approach to quality management can significantly enhance medication safety.
  • Effective communication and documentation are vital components of medication error prevention strategies.